FLAM
JANX icon

First Light Asset Management’s Janux Therapeutics JANX Stock Holding History

First Light Asset Management’s Portfolio JANX Stock Details JANX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-149,596
Closed -$3.46M – 45
2025
Q2 		$3.46M Sell
149,596
-509,228
-77% -$13.4M 0.45% 36
2025
Q1 		$17.8M Buy
658,824
+345,042
+110% +$13M 2.03% 19
2024
Q4 		$16.8M Buy
+313,782
New +$16.6M 1.61% 19

Other funds holding JANX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

First Light Asset Management's JANX Position: Q3 2025 in Review

First Light Asset Management sold out of Janux Therapeutics (JANX) in Q3 2025, closing a stake of 149,596 shares — an estimated $3.46M sold.

First Light Asset Management first reported a position in JANX in Q4 2024 and held it in 3 quarters. The position peaked at $17.8M in Q1 2025. 174 funds tracked by Wall St. Rank hold JANX as of Q3 2025.

  • First Light Asset Management reported no remaining Janux Therapeutics position as of Q3 2025 after selling out during the quarter.
  • First Light Asset Management sold 149,596 Janux Therapeutics shares in Q3 2025, an estimated $3.46M.
  • First Light Asset Management first reported a position in Janux Therapeutics in Q4 2024 and held it in 3 quarters.
  • First Light Asset Management's Janux Therapeutics position peaked at $17.8M in Q1 2025.
  • 174 funds tracked by Wall St. Rank held Janux Therapeutics as of Q3 2025.

Based on First Light Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.